65F0.	2019-nCoV (novel coronavirus) vaccination
65F0100	Administration of first dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine
65F0200	2019-nCoV (novel coronavirus) vaccination
65F0600	SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination
65F0700	Immunisation course to achieve immunity against SARS-CoV-2
65F0800	Immunisation course to maintain protection against SARS-CoV-2
65F0900	Administration of third dose of SARS-CoV-2 vaccine
65F0A00	Administration of fourth dose of SARS-CoV-2 vaccine
9bJ..	COVID-19 mRNA Vaccine BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer-BioNTech)
